DoubleClick的个人主页 - 老虎社区

DoubleClick

DoubleClick

暂无个人介绍

IP属地：未知

19关注

5粉丝

0主题

0勋章

2021-11-25

$iQiyi Inc.(IQ)$ 是我的第一次

@小虎活动:【感恩回馈】说说你和老虎的第一次

2021-11-25

小米就是要放长线钓大鱼！$XIAOMI-W(01810)$

@话题虎:小米净利润大长25.4%！为什么又跌了？何时能抄底？

2021-11-24

我的计划是等着看

@Buy_Sell:🚀【11月24日】涨跌不一，油价上演大逆转！今天什么值得买

2021-11-23

抱歉，原内容已删除

2021-11-21

$Apple(AAPL)$Ride the upward momentum!

2021-11-17

$iQiyi Inc.(IQ)$For long term play? 💎✊🏻

2021-11-15

Here for the coins!

@期权异动观察:11.15期权异动观察，AMD反复异动

2021-11-11

Lol need more words in the thesaurus for “drop”.

Continued Consolidation Called For Singapore Shares

2021-11-04

Happy Diwali Everyone!

2021-11-01

Nice!

2 Growth Stocks That Could Deliver 1,000% Returns

2021-06-20

Latest

抱歉，原内容已删除

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3574933488250733","uuid":"3574933488250733","gmtCreate":1611839465354,"gmtModify":1635779542349,"name":"DoubleClick","pinyin":"doubleclick","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":5,"headSize":19,"tweetSize":11,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.06.15","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.03.23","exceedPercentage":"60.73%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":874477757,"gmtCreate":1637818653179,"gmtModify":1637818653328,"author":{"id":"3574933488250733","authorId":"3574933488250733","name":"DoubleClick","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574933488250733","authorIdStr":"3574933488250733"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/IQ\">$iQiyi Inc.(IQ)$</a> 是我的第一次","listText":"<a href=\"https://laohu8.com/S/IQ\">$iQiyi Inc.(IQ)$</a> 是我的第一次","text":"$iQiyi Inc.(IQ)$ 是我的第一次","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/874477757","repostId":"875266611","repostType":1,"repost":{"id":875266611,"gmtCreate":1637659026330,"gmtModify":1637929617182,"author":{"id":"36984908995200","authorId":"36984908995200","name":"小虎活动","avatar":"https://static.tigerbbs.com/9e396d03155923b283948d2dec9191f8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"36984908995200","authorIdStr":"36984908995200"},"themes":[],"title":"【感恩回馈】说说你和老虎的第一次","htmlText":"感恩节马上要到了，小虎提醒：感恩节周四(11月25日)美股休市哦！感恩节翌日(26日)美股提前3小时收盘~ 为了回馈广大虎友们的支持与陪伴，小虎君为大家准备了一些小礼物，参与即可获赠66虎币，如果你愿意多聊2句，还有机会获得小虎全套盲盒。 不知不觉，老虎已经成立7年了， 在过去年的7年，我们认识了很多新老朋友 可曾记得你是何时加入老虎的？ 又是缘何来到这里？ 【参与方式】 本帖留言说出 「你和老虎的第一次」 你发布的第一个帖子是什么？ 你关注的第一个好友是谁？ 你关注/交易的第一只股票是什么？ 【活动奖励】 凡是参与晒单的虎友均可获得66虎币，除此之外，还有机会获得以下奖励： 知己奖：我们会选取“第一条帖子”发帖时间最早的虎友赠予1套小虎盲盒手办（5个） 人气奖：我们会选取评论获赞量最高的3位虎友，随机赠予小虎盲盒手办1个 优质奖：我们会随机选取评论优质有趣的虎友，随机赠予小虎盲盒手办1个 【活动时间】： 2021年11月23日-11月29日 【特别说明】 水贴，重复内容，广告，恶意营销等属于无效内容； 文章需原创并首发于老虎，并且版权归老虎社区所有； 本次活动中用户所提到的标的，仅供参考，不构成投资建议，据此操作，风险自负； 活动最终解释权归老虎社区所有； 若对本次活动有不解之处，可在此贴留言，或微信虎妞（微信号：itiger2014）咨询。 欢迎大家在下贴评论区留言说说「你和老虎的第一次」，你发布的第一个帖子是什么？你关注的第一个好友是谁？你关注/交易的第一只股票是什么？参与即可获赠66虎币，如果你愿意多聊2句，还有机会获得小虎全套盲盒。","listText":"感恩节马上要到了，小虎提醒：感恩节周四(11月25日)美股休市哦！感恩节翌日(26日)美股提前3小时收盘~ 为了回馈广大虎友们的支持与陪伴，小虎君为大家准备了一些小礼物，参与即可获赠66虎币，如果你愿意多聊2句，还有机会获得小虎全套盲盒。 不知不觉，老虎已经成立7年了， 在过去年的7年，我们认识了很多新老朋友 可曾记得你是何时加入老虎的？ 又是缘何来到这里？ 【参与方式】 本帖留言说出 「你和老虎的第一次」 你发布的第一个帖子是什么？ 你关注的第一个好友是谁？ 你关注/交易的第一只股票是什么？ 【活动奖励】 凡是参与晒单的虎友均可获得66虎币，除此之外，还有机会获得以下奖励： 知己奖：我们会选取“第一条帖子”发帖时间最早的虎友赠予1套小虎盲盒手办（5个） 人气奖：我们会选取评论获赞量最高的3位虎友，随机赠予小虎盲盒手办1个 优质奖：我们会随机选取评论优质有趣的虎友，随机赠予小虎盲盒手办1个 【活动时间】： 2021年11月23日-11月29日 【特别说明】 水贴，重复内容，广告，恶意营销等属于无效内容； 文章需原创并首发于老虎，并且版权归老虎社区所有； 本次活动中用户所提到的标的，仅供参考，不构成投资建议，据此操作，风险自负； 活动最终解释权归老虎社区所有； 若对本次活动有不解之处，可在此贴留言，或微信虎妞（微信号：itiger2014）咨询。 欢迎大家在下贴评论区留言说说「你和老虎的第一次」，你发布的第一个帖子是什么？你关注的第一个好友是谁？你关注/交易的第一只股票是什么？参与即可获赠66虎币，如果你愿意多聊2句，还有机会获得小虎全套盲盒。","text":"感恩节马上要到了，小虎提醒：感恩节周四(11月25日)美股休市哦！感恩节翌日(26日)美股提前3小时收盘~ 为了回馈广大虎友们的支持与陪伴，小虎君为大家准备了一些小礼物，参与即可获赠66虎币，如果你愿意多聊2句，还有机会获得小虎全套盲盒。 不知不觉，老虎已经成立7年了， 在过去年的7年，我们认识了很多新老朋友 可曾记得你是何时加入老虎的？ 又是缘何来到这里？ 【参与方式】 本帖留言说出 「你和老虎的第一次」 你发布的第一个帖子是什么？ 你关注的第一个好友是谁？ 你关注/交易的第一只股票是什么？ 【活动奖励】 凡是参与晒单的虎友均可获得66虎币，除此之外，还有机会获得以下奖励： 知己奖：我们会选取“第一条帖子”发帖时间最早的虎友赠予1套小虎盲盒手办（5个） 人气奖：我们会选取评论获赞量最高的3位虎友，随机赠予小虎盲盒手办1个 优质奖：我们会随机选取评论优质有趣的虎友，随机赠予小虎盲盒手办1个 【活动时间】： 2021年11月23日-11月29日 【特别说明】 水贴，重复内容，广告，恶意营销等属于无效内容； 文章需原创并首发于老虎，并且版权归老虎社区所有； 本次活动中用户所提到的标的，仅供参考，不构成投资建议，据此操作，风险自负； 活动最终解释权归老虎社区所有； 若对本次活动有不解之处，可在此贴留言，或微信虎妞（微信号：itiger2014）咨询。 欢迎大家在下贴评论区留言说说「你和老虎的第一次」，你发布的第一个帖子是什么？你关注的第一个好友是谁？你关注/交易的第一只股票是什么？参与即可获赠66虎币，如果你愿意多聊2句，还有机会获得小虎全套盲盒。","images":[{"img":"https://static.tigerbbs.com/b56d1364489aaafc34e363d2b2b842a8","width":"1462","height":"818"}],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/875266611","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":446,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":874434632,"gmtCreate":1637809697526,"gmtModify":1637809697589,"author":{"id":"3574933488250733","authorId":"3574933488250733","name":"DoubleClick","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574933488250733","authorIdStr":"3574933488250733"},"themes":[],"htmlText":"小米就是要放长线钓大鱼！<a href=\"https://laohu8.com/S/01810\">$XIAOMI-W(01810)$</a>","listText":"小米就是要放长线钓大鱼！<a href=\"https://laohu8.com/S/01810\">$XIAOMI-W(01810)$</a>","text":"小米就是要放长线钓大鱼！$XIAOMI-W(01810)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/874434632","repostId":"874394828","repostType":1,"repost":{"id":874394828,"gmtCreate":1637727980561,"gmtModify":1637730601856,"author":{"id":"3502767768442965","authorId":"3502767768442965","name":"话题虎","avatar":"https://static.tigerbbs.com/d418c2def5dc1d094b03270b450f71ce","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3502767768442965","authorIdStr":"3502767768442965"},"themes":[],"title":"小米净利润大长25.4%！为什么又跌了？何时能抄底？","htmlText":" 昨天，小米发布Q3财报： 营收781亿元，同比增长8.2%；净利润52亿元，同比增长25.4%。 分业务来看： 智能手机： 三季度收入478亿元。 手机销售单价同比增长6.7%，达到1,090.5元，整体毛利率同比增长4.4个百分点，达到12.8%； 本季度智能手机出货量4,390万部，排名世界第三，前三季出货量与去年全年相当； 高端旗舰手机出货量近1800万台，占比超12%。 IoT与生活消费产品： 三季度收入209亿元，同比增长15.5%； 平板、智能电视、空调出货量持续增加； 在可穿戴产品，第三季度全球市场份额排名第二。 互联网服务业务： 三季度收入73亿元，同比增长27.1%，创历史新高； 毛利率73.6%，同比提升13.1个百分点； 广告收入48亿元，同比增长44.7%； 游戏收入10亿元，同比增长25.0%。 从地区上看，三季度： 境外收入，占比高达52.4%； 小米手机在全球11个国家和地区市占率排名第一，在全球59个国家和地区市占率排名前五；在印度市场连续第16个季度保持出货量第一。 智能电动汽车和其他业务： 团队成员已超过500人，预计2024年上半年正式量产； AIoT平台已连接的IoT设备（不包括智能手机、平板及笔记本计算机）数首次突破4&nbsp;亿，同比增长33.1%； 小米在中国大陆的零售店总数已突破10,000家。 小话感觉小米又交出了一份非常ok的财报，可是为啥股价大跌呢？ 想不通。 …… 最后，大家聊一聊： 你认为小米的财报ok吗？小米跌到什么时候能抄底？ 精彩留言用户可获得888社区积分噢！ <a target=\"_blank\" href=\"https://laohu8.com/S/01810\">$小米集团-W(01810)$</a>","listText":" 昨天，小米发布Q3财报： 营收781亿元，同比增长8.2%；净利润52亿元，同比增长25.4%。 分业务来看： 智能手机： 三季度收入478亿元。 手机销售单价同比增长6.7%，达到1,090.5元，整体毛利率同比增长4.4个百分点，达到12.8%； 本季度智能手机出货量4,390万部，排名世界第三，前三季出货量与去年全年相当； 高端旗舰手机出货量近1800万台，占比超12%。 IoT与生活消费产品： 三季度收入209亿元，同比增长15.5%； 平板、智能电视、空调出货量持续增加； 在可穿戴产品，第三季度全球市场份额排名第二。 互联网服务业务： 三季度收入73亿元，同比增长27.1%，创历史新高； 毛利率73.6%，同比提升13.1个百分点； 广告收入48亿元，同比增长44.7%； 游戏收入10亿元，同比增长25.0%。 从地区上看，三季度： 境外收入，占比高达52.4%； 小米手机在全球11个国家和地区市占率排名第一，在全球59个国家和地区市占率排名前五；在印度市场连续第16个季度保持出货量第一。 智能电动汽车和其他业务： 团队成员已超过500人，预计2024年上半年正式量产； AIoT平台已连接的IoT设备（不包括智能手机、平板及笔记本计算机）数首次突破4&nbsp;亿，同比增长33.1%； 小米在中国大陆的零售店总数已突破10,000家。 小话感觉小米又交出了一份非常ok的财报，可是为啥股价大跌呢？ 想不通。 …… 最后，大家聊一聊： 你认为小米的财报ok吗？小米跌到什么时候能抄底？ 精彩留言用户可获得888社区积分噢！ <a target=\"_blank\" href=\"https://laohu8.com/S/01810\">$小米集团-W(01810)$</a>","text":"昨天，小米发布Q3财报： 营收781亿元，同比增长8.2%；净利润52亿元，同比增长25.4%。 分业务来看： 智能手机： 三季度收入478亿元。 手机销售单价同比增长6.7%，达到1,090.5元，整体毛利率同比增长4.4个百分点，达到12.8%； 本季度智能手机出货量4,390万部，排名世界第三，前三季出货量与去年全年相当； 高端旗舰手机出货量近1800万台，占比超12%。 IoT与生活消费产品： 三季度收入209亿元，同比增长15.5%； 平板、智能电视、空调出货量持续增加； 在可穿戴产品，第三季度全球市场份额排名第二。 互联网服务业务： 三季度收入73亿元，同比增长27.1%，创历史新高； 毛利率73.6%，同比提升13.1个百分点； 广告收入48亿元，同比增长44.7%； 游戏收入10亿元，同比增长25.0%。 从地区上看，三季度： 境外收入，占比高达52.4%； 小米手机在全球11个国家和地区市占率排名第一，在全球59个国家和地区市占率排名前五；在印度市场连续第16个季度保持出货量第一。 智能电动汽车和其他业务： 团队成员已超过500人，预计2024年上半年正式量产； AIoT平台已连接的IoT设备（不包括智能手机、平板及笔记本计算机）数首次突破4 亿，同比增长33.1%； 小米在中国大陆的零售店总数已突破10,000家。 小话感觉小米又交出了一份非常ok的财报，可是为啥股价大跌呢？ 想不通。 …… 最后，大家聊一聊： 你认为小米的财报ok吗？小米跌到什么时候能抄底？ 精彩留言用户可获得888社区积分噢！ $小米集团-W(01810)$","images":[{"img":"https://static.tigerbbs.com/3f5a17d57ed7aba34cdfe013be4ef460","width":"1024","height":"640"}],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/874394828","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"subType":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":549,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":874261442,"gmtCreate":1637793878586,"gmtModify":1637793878691,"author":{"id":"3574933488250733","authorId":"3574933488250733","name":"DoubleClick","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574933488250733","authorIdStr":"3574933488250733"},"themes":[],"htmlText":"我的计划是等着看","listText":"我的计划是等着看","text":"我的计划是等着看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/874261442","repostId":"874922613","repostType":1,"repost":{"id":874922613,"gmtCreate":1637722036227,"gmtModify":1637723087352,"author":{"id":"3527667596890271","authorId":"3527667596890271","name":"Buy_Sell","avatar":"https://static.tigerbbs.com/a5f0ed79a338c758a22e0b4ea13bf9d2","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3527667596890271","authorIdStr":"3527667596890271"},"themes":[],"title":"🚀【11月24日】涨跌不一，油价上演大逆转！今天什么值得买","htmlText":"聊聊今日份的交易想法，包括对于大盘走势后续的看法？看涨/看跌哪只股票、晒晒单等等。 港股市场 11月24日讯，港股三大指数开盘涨跌不一，恒指涨0.08%报24672点，国指跌0.02%报8825点，恒生科技指数跌0.1%报6317点。 盘面上，大型科技股多数延续跌势，<a target=\"_blank\" href=\"https://laohu8.com/S/09999\">$网易-S(09999)$</a> 跌2.44%，<a target=\"_blank\" href=\"https://laohu8.com/S/00700\">$腾讯控股(00700)$</a> 、<a target=\"_blank\" href=\"https://laohu8.com/S/09988\">$阿里巴巴-SW(09988)$</a> 、<a target=\"_blank\" href=\"https://laohu8.com/S/09618\">$京东集团-SW(09618)$</a> 均跌超1%，<a target=\"_blank\" href=\"https://laohu8.com/S/01024\">$快手-W(01024)$</a> 大涨4.5%；家电股、汽车股、半导体股、体育用品股、建材水泥股、燃气股普跌，内房股、保险股涨跌参半；国际油价上涨，石油股集体高开，<a target=\"_blank\" href=\"https://laohu8.com/S/00857\">$中国石油股份(00857)$</a> 涨超3%，恒大系继续走强，恒腾网络再涨3.58%。 <a target=\"_blank\" href=\"https://laohu8.com/S/01024\">$快手-W(01024)$</a> 绩后涨超4%，第三季度收入同比增33.4%，调整后净亏损48.22亿元。","listText":"聊聊今日份的交易想法，包括对于大盘走势后续的看法？看涨/看跌哪只股票、晒晒单等等。 港股市场 11月24日讯，港股三大指数开盘涨跌不一，恒指涨0.08%报24672点，国指跌0.02%报8825点，恒生科技指数跌0.1%报6317点。 盘面上，大型科技股多数延续跌势，<a target=\"_blank\" href=\"https://laohu8.com/S/09999\">$网易-S(09999)$</a> 跌2.44%，<a target=\"_blank\" href=\"https://laohu8.com/S/00700\">$腾讯控股(00700)$</a> 、<a target=\"_blank\" href=\"https://laohu8.com/S/09988\">$阿里巴巴-SW(09988)$</a> 、<a target=\"_blank\" href=\"https://laohu8.com/S/09618\">$京东集团-SW(09618)$</a> 均跌超1%，<a target=\"_blank\" href=\"https://laohu8.com/S/01024\">$快手-W(01024)$</a> 大涨4.5%；家电股、汽车股、半导体股、体育用品股、建材水泥股、燃气股普跌，内房股、保险股涨跌参半；国际油价上涨，石油股集体高开，<a target=\"_blank\" href=\"https://laohu8.com/S/00857\">$中国石油股份(00857)$</a> 涨超3%，恒大系继续走强，恒腾网络再涨3.58%。 <a target=\"_blank\" href=\"https://laohu8.com/S/01024\">$快手-W(01024)$</a> 绩后涨超4%，第三季度收入同比增33.4%，调整后净亏损48.22亿元。","text":"聊聊今日份的交易想法，包括对于大盘走势后续的看法？看涨/看跌哪只股票、晒晒单等等。 港股市场 11月24日讯，港股三大指数开盘涨跌不一，恒指涨0.08%报24672点，国指跌0.02%报8825点，恒生科技指数跌0.1%报6317点。 盘面上，大型科技股多数延续跌势，$网易-S(09999)$ 跌2.44%，$腾讯控股(00700)$ 、$阿里巴巴-SW(09988)$ 、$京东集团-SW(09618)$ 均跌超1%，$快手-W(01024)$ 大涨4.5%；家电股、汽车股、半导体股、体育用品股、建材水泥股、燃气股普跌，内房股、保险股涨跌参半；国际油价上涨，石油股集体高开，$中国石油股份(00857)$ 涨超3%，恒大系继续走强，恒腾网络再涨3.58%。 $快手-W(01024)$ 绩后涨超4%，第三季度收入同比增33.4%，调整后净亏损48.22亿元。","images":[{"img":"https://static.tigerbbs.com/8c224c9889536a14f83eca563ae0bb07","width":"666","height":"284"}],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/874922613","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"subType":2,"comments":[],"imageCount":2,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":886,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875615904,"gmtCreate":1637642120721,"gmtModify":1637642124644,"author":{"id":"3574933488250733","authorId":"3574933488250733","name":"DoubleClick","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574933488250733","authorIdStr":"3574933488250733"},"themes":[],"htmlText":"[Cool]&nbsp;","listText":"[Cool]&nbsp;","text":"[Cool]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/875615904","repostId":"1107351089","repostType":4,"isVote":1,"tweetType":1,"viewCount":764,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":872837844,"gmtCreate":1637471088221,"gmtModify":1637471088326,"author":{"id":"3574933488250733","authorId":"3574933488250733","name":"DoubleClick","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574933488250733","authorIdStr":"3574933488250733"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>Ride the upward momentum!","listText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>Ride the upward momentum!","text":"$Apple(AAPL)$Ride the upward momentum!","images":[{"img":"https://static.tigerbbs.com/5fa407a19830d6fd52b2503f25ec1c6b","width":"750","height":"2298"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/872837844","isVote":1,"tweetType":1,"viewCount":1324,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":878020564,"gmtCreate":1637126588784,"gmtModify":1637126588955,"author":{"id":"3574933488250733","authorId":"3574933488250733","name":"DoubleClick","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574933488250733","authorIdStr":"3574933488250733"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/IQ\">$iQiyi Inc.(IQ)$</a>For long term play? 💎✊🏻","listText":"<a href=\"https://laohu8.com/S/IQ\">$iQiyi Inc.(IQ)$</a>For long term play? 💎✊🏻","text":"$iQiyi Inc.(IQ)$For long term play? 💎✊🏻","images":[{"img":"https://static.tigerbbs.com/bf5a60bc4debb04026b17b9cdc2ecc62","width":"750","height":"2443"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":11,"repostSize":0,"link":"https://laohu8.com/post/878020564","isVote":1,"tweetType":1,"viewCount":901,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":873789420,"gmtCreate":1636987209261,"gmtModify":1636987209401,"author":{"id":"3574933488250733","authorId":"3574933488250733","name":"DoubleClick","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574933488250733","authorIdStr":"3574933488250733"},"themes":[],"htmlText":"Here for the coins!","listText":"Here for the coins!","text":"Here for the coins!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/873789420","repostId":"873287761","repostType":1,"repost":{"id":873287761,"gmtCreate":1636948480350,"gmtModify":1636957657847,"author":{"id":"3527667583497005","authorId":"3527667583497005","name":"期权异动观察","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3527667583497005","authorIdStr":"3527667583497005"},"themes":[],"title":"11.15期权异动观察，AMD反复异动","htmlText":"<a target=\"_blank\" href=\"https://laohu8.com/S/ACB\">$奥罗拉大麻公司(ACB)$</a>&nbsp;在<a target=\"_blank\" href=\"https://laohu8.com/S/SNDL\">$Sundial Growers Inc.(SNDL)$</a> 的带动下，周五大麻股出现了集体异动，ACB公司评级获得了部分评级机构上调，后续走势看大麻bank整体走势。坎托菲茨杰拉德公司：维持Aurora Cannabis Inc(ACB.US)中性评级, 目标价由9.60美元调整至10.75美元。 <a target=\"_blank\" href=\"https://laohu8.com/S/AMD\">$AMD(AMD)$</a> 最近股价频繁异动，消息面趋于平静，股价依然处于强势状态。 <a target=\"_blank\" href=\"https://laohu8.com/S/ATVI\">$动视暴雪(ATVI)$</a>财报不及预期暴跌之后，最近走稳开始向上拉升， 消息面平静。 <a target=\"_blank\" href=\"https://laohu8.com/S/TTD\">$Trade Desk Inc.(TTD)$</a>最近也是二次异动，该股依然处于强势上攻，奥本海默在11.9日将公司的目标价从95美元上调至100美元。 <a target=\"_blank\" href=\"https://laohu8.com/S/TSLA\">$特斯拉(TSLA)$</a> 上周下跌15%，马斯克持续减持股份，短期走势看震荡，目测这个月马斯克就可以将手里的股份减持完毕。 <a href=\"https://laohu8.com/TW/854739948\" target=\"_blank\">目前模拟账户也已经上线了期权交易功能，</a>","listText":"<a target=\"_blank\" href=\"https://laohu8.com/S/ACB\">$奥罗拉大麻公司(ACB)$</a>&nbsp;在<a target=\"_blank\" href=\"https://laohu8.com/S/SNDL\">$Sundial Growers Inc.(SNDL)$</a> 的带动下，周五大麻股出现了集体异动，ACB公司评级获得了部分评级机构上调，后续走势看大麻bank整体走势。坎托菲茨杰拉德公司：维持Aurora Cannabis Inc(ACB.US)中性评级, 目标价由9.60美元调整至10.75美元。 <a target=\"_blank\" href=\"https://laohu8.com/S/AMD\">$AMD(AMD)$</a> 最近股价频繁异动，消息面趋于平静，股价依然处于强势状态。 <a target=\"_blank\" href=\"https://laohu8.com/S/ATVI\">$动视暴雪(ATVI)$</a>财报不及预期暴跌之后，最近走稳开始向上拉升， 消息面平静。 <a target=\"_blank\" href=\"https://laohu8.com/S/TTD\">$Trade Desk Inc.(TTD)$</a>最近也是二次异动，该股依然处于强势上攻，奥本海默在11.9日将公司的目标价从95美元上调至100美元。 <a target=\"_blank\" href=\"https://laohu8.com/S/TSLA\">$特斯拉(TSLA)$</a> 上周下跌15%，马斯克持续减持股份，短期走势看震荡，目测这个月马斯克就可以将手里的股份减持完毕。 <a href=\"https://laohu8.com/TW/854739948\" target=\"_blank\">目前模拟账户也已经上线了期权交易功能，</a>","text":"$奥罗拉大麻公司(ACB)$ 在$Sundial Growers Inc.(SNDL)$ 的带动下，周五大麻股出现了集体异动，ACB公司评级获得了部分评级机构上调，后续走势看大麻bank整体走势。坎托菲茨杰拉德公司：维持Aurora Cannabis Inc(ACB.US)中性评级, 目标价由9.60美元调整至10.75美元。 $AMD(AMD)$ 最近股价频繁异动，消息面趋于平静，股价依然处于强势状态。 $动视暴雪(ATVI)$财报不及预期暴跌之后，最近走稳开始向上拉升， 消息面平静。 $Trade Desk Inc.(TTD)$最近也是二次异动，该股依然处于强势上攻，奥本海默在11.9日将公司的目标价从95美元上调至100美元。 $特斯拉(TSLA)$ 上周下跌15%，马斯克持续减持股份，短期走势看震荡，目测这个月马斯克就可以将手里的股份减持完毕。 目前模拟账户也已经上线了期权交易功能，","images":[{"img":"https://static.tigerbbs.com/913d99ad732154469e49fa9467361f77","width":"799","height":"698"}],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/873287761","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":743,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":870345013,"gmtCreate":1636590325446,"gmtModify":1636590325446,"author":{"id":"3574933488250733","authorId":"3574933488250733","name":"DoubleClick","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574933488250733","authorIdStr":"3574933488250733"},"themes":[],"htmlText":"Lol need more words in the thesaurus for “drop”.&nbsp;","listText":"Lol need more words in the thesaurus for “drop”.&nbsp;","text":"Lol need more words in the thesaurus for “drop”.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/870345013","repostId":"1163617251","repostType":2,"repost":{"id":"1163617251","kind":"news","pubTimestamp":1636589713,"share":"https://www.laohu8.com/m/news/1163617251?lang=&edition=full","pubTime":"2021-11-11 08:15","market":"sg","language":"en","title":"Continued Consolidation Called For Singapore Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1163617251","media":"RTTNews","summary":"(RTTNews) - The Singapore stock market has finished lower in two straight sessions, dropping more th","content":"<p>(RTTNews) - The Singapore stock market has finished lower in two straight sessions, dropping more than 30 points or 1 percent along the way. The Straits Times Index now sits just above the 3,230-point plateau and it may extend its losses on Thursday.</p>\n<p>The global forecast for the Asian markets suggests consolidation on inflation concerns and a drop in crude oil prices. The European markets were up and the U.S. bourses were down and the Asian markets figure to follow the latter lead.</p>\n<p>The STI finished modestly lower on Wednesday following losses from the financial shares, property stocks and industrial issues.</p>\n<p>For the day, the index shed 12.10 points or 0.37 percent to finish at 3,231.32 after trading between 3,218.31 and 3,246.00. Volume was 2.03 billion shares worth 1.05 billion Singapore dollars. There were 256 decliners and 204 gainers.</p>\n<p>Among the actives, Ascendas REIT fell 0.32 percent, while <a href=\"https://laohu8.com/S/CHCO\">City</a> Developments rose 0.28 percent, Comfort DelGro and DBS Group both skidded 0.62 percent, Dairy Farm International plummeted 1.17 percent, Jardine Cycle advanced 1.02 percent, Jardine Matheson climbed 1.16 percent, Mapletree Commercial Trust dropped 0.47 percent, Mapletree Logistics Trust sank 0.51 percent, Oversea-Chinese Banking Corporation lost 0.34 percent, SATS surrendered 0.95 percent, SembCorp Industries tumbled 0.96 percent, Singapore Airlines tanked 1.09 percent, Singapore Exchange eased 0.21 percent, Singapore Technologies Engineering gained 0.79 percent, SingTel declined 0.78 percent, <a href=\"https://laohu8.com/S/UBNK\">United</a> Overseas Bank retreated 0.75 percent, Wilmar International plunged 1.14 percent, Yangzijiang Shipbuilding added 0.80 percent and Keppel Corp, Genting Singapore, CapitaLand, CapitaLand Integrated Commercial Trust, Thai Beverage and Singapore Press Holdings were unchanged.</p>\n<p>The lead from Wall Street is broadly negative as the major averages opened slightly lower on Wednesday but saw the losses accelerate as the day progressed to finish solidly under water.</p>\n<p>The Dow tumbled 240.04 points or 0.66 percent to finish at 36,079.94, while the NASDAQ plunged 263.84 points or 1.66 percent to close at 15,622.71 and the S&amp;P 500 sank 38.54 points or 0.82 percent to end at 4,646.71.</p>\n<p>Concerns about inflation contributed to the weakness on Wall Street after the Labor Department released a report showing consumer prices increased by more than expected in October, lifting the annual rate of price growth to its highest level in over thirty years.</p>\n<p>The acceleration in the rate of consumer price inflation raised concerns about the outlook for interest rates even though the Federal Reserve has signaled it will not be in a hurry to begin raising rates.</p>\n<p>Also, a separate report from the Labor Department showed another modest decrease in first-time claims for U.S. unemployment benefits last week.</p>\n<p>Crude oil prices declined sharply on Wednesday, snapping a three-day winning streak after data showed an increase in U.S. crude stockpiles last week. <a href=\"https://laohu8.com/S/WSTC\">West</a> Texas Intermediate Crude oil futures for December ended down by $2.81 or 3.3 percent at $81.34 a barrel.</p>","source":"lsy1603171495471","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Continued Consolidation Called For Singapore Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nContinued Consolidation Called For Singapore Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-11 08:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.nasdaq.com/articles/continued-consolidation-called-for-singapore-shares><strong>RTTNews</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(RTTNews) - The Singapore stock market has finished lower in two straight sessions, dropping more than 30 points or 1 percent along the way. The Straits Times Index now sits just above the 3,230-point...</p>\n\n<a href=\"https://www.nasdaq.com/articles/continued-consolidation-called-for-singapore-shares\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.nasdaq.com/articles/continued-consolidation-called-for-singapore-shares","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1163617251","content_text":"(RTTNews) - The Singapore stock market has finished lower in two straight sessions, dropping more than 30 points or 1 percent along the way. The Straits Times Index now sits just above the 3,230-point plateau and it may extend its losses on Thursday.\nThe global forecast for the Asian markets suggests consolidation on inflation concerns and a drop in crude oil prices. The European markets were up and the U.S. bourses were down and the Asian markets figure to follow the latter lead.\nThe STI finished modestly lower on Wednesday following losses from the financial shares, property stocks and industrial issues.\nFor the day, the index shed 12.10 points or 0.37 percent to finish at 3,231.32 after trading between 3,218.31 and 3,246.00. Volume was 2.03 billion shares worth 1.05 billion Singapore dollars. There were 256 decliners and 204 gainers.\nAmong the actives, Ascendas REIT fell 0.32 percent, while City Developments rose 0.28 percent, Comfort DelGro and DBS Group both skidded 0.62 percent, Dairy Farm International plummeted 1.17 percent, Jardine Cycle advanced 1.02 percent, Jardine Matheson climbed 1.16 percent, Mapletree Commercial Trust dropped 0.47 percent, Mapletree Logistics Trust sank 0.51 percent, Oversea-Chinese Banking Corporation lost 0.34 percent, SATS surrendered 0.95 percent, SembCorp Industries tumbled 0.96 percent, Singapore Airlines tanked 1.09 percent, Singapore Exchange eased 0.21 percent, Singapore Technologies Engineering gained 0.79 percent, SingTel declined 0.78 percent, United Overseas Bank retreated 0.75 percent, Wilmar International plunged 1.14 percent, Yangzijiang Shipbuilding added 0.80 percent and Keppel Corp, Genting Singapore, CapitaLand, CapitaLand Integrated Commercial Trust, Thai Beverage and Singapore Press Holdings were unchanged.\nThe lead from Wall Street is broadly negative as the major averages opened slightly lower on Wednesday but saw the losses accelerate as the day progressed to finish solidly under water.\nThe Dow tumbled 240.04 points or 0.66 percent to finish at 36,079.94, while the NASDAQ plunged 263.84 points or 1.66 percent to close at 15,622.71 and the S&P 500 sank 38.54 points or 0.82 percent to end at 4,646.71.\nConcerns about inflation contributed to the weakness on Wall Street after the Labor Department released a report showing consumer prices increased by more than expected in October, lifting the annual rate of price growth to its highest level in over thirty years.\nThe acceleration in the rate of consumer price inflation raised concerns about the outlook for interest rates even though the Federal Reserve has signaled it will not be in a hurry to begin raising rates.\nAlso, a separate report from the Labor Department showed another modest decrease in first-time claims for U.S. unemployment benefits last week.\nCrude oil prices declined sharply on Wednesday, snapping a three-day winning streak after data showed an increase in U.S. crude stockpiles last week. West Texas Intermediate Crude oil futures for December ended down by $2.81 or 3.3 percent at $81.34 a barrel.","news_type":1},"isVote":1,"tweetType":1,"viewCount":977,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":848639075,"gmtCreate":1635993150614,"gmtModify":1635993150735,"author":{"id":"3574933488250733","authorId":"3574933488250733","name":"DoubleClick","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574933488250733","authorIdStr":"3574933488250733"},"themes":[],"htmlText":"Happy Diwali Everyone!&nbsp;","listText":"Happy Diwali Everyone!&nbsp;","text":"Happy Diwali Everyone!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/848639075","isVote":1,"tweetType":1,"viewCount":936,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":849880046,"gmtCreate":1635741983209,"gmtModify":1635741983209,"author":{"id":"3574933488250733","authorId":"3574933488250733","name":"DoubleClick","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574933488250733","authorIdStr":"3574933488250733"},"themes":[],"htmlText":"Nice!","listText":"Nice!","text":"Nice!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/849880046","repostId":"1164035523","repostType":2,"repost":{"id":"1164035523","kind":"news","pubTimestamp":1635736469,"share":"https://www.laohu8.com/m/news/1164035523?lang=&edition=full","pubTime":"2021-11-01 11:14","market":"us","language":"en","title":"2 Growth Stocks That Could Deliver 1,000% Returns","url":"https://stock-news.laohu8.com/highlight/detail?id=1164035523","media":"Motley Fool","summary":"Thanks to the ongoing innovation revolutions in both the tech and healthcare sectors, shareholders h","content":"<p>Thanks to the ongoing innovation revolutions in both the tech and healthcare sectors, shareholders have been enjoying historic returns on capital over the past decade. For example, the central nervous system disorder drug specialist&nbsp;<b>Axsome Therapeutics</b>, the cancer specialist&nbsp;<b>Exelixis</b>, and the electric car pioneer&nbsp;<b>Tesla</b>&nbsp;have all delivered tenfold returns for investors who bought these names at their low points.</p>\n<p>Which stocks might be the next Axsome, Exelixis, or Tesla from a growth standpoint? The cancer/rare disease specialist&nbsp;<b>Mereo BioPharma Group</b>(NASDAQ:MREO)and the diabetes-focused medical device company&nbsp;<b>Senseonics Holdings</b>(NYSEMKT:SENS)could both be gearing up for a monstrous run higher soon. In fact, these two low-priced&nbsp;healthcare stocks&nbsp;have a decent shot at generating 1,000%-plus returns for their shareholders within the next two to three years.</p>\n<p>Here's a brief overview on the risks and potential rewards associated with each of these promising growth vehicles.</p>\n<p><b>Mereo BioPharma: A bet on the future of immunotherapy</b></p>\n<p>The London-based biopharma Mereo hasn't exactly set the world on fire since its American depository shares (ADS) made their debut on the Nasdaq stock exchange. Keeping with this theme, the biotech's ADSes have lost approximately 65% of their value since April 2019. This steady downward trend shouldn't scare away aggressive investors, however. Mereo's plunging share price, after all, is more about Mr. Market's well-known impatience with clinical-stage biotechs, rather than the company's underlying value proposition.</p>\n<p>What's the scoop? Mereo is a small-cap company with six assets under development for both cancer and rare diseases. However, the one drug candidate that could undoubtedly send the company's shares rocketing higher is the&nbsp;anti-TIGIT therapy&nbsp;known as etigilimab. Several major drug companies, such as&nbsp;<b>BeiGene</b>,<b>Bristol Myers Squibb</b>,<b>Merck</b>, and&nbsp;<b>Roche</b>, have anti-TIGIT therapies under development due to their potential to boost the efficacy and durability of cancer immunotherapy treatments in general. Mereo's etigilimab is currently in a combined phase 1/2 basket study to evaluate its utility as part of combination treament, along with Bristol's megablockbuster checkpoint inhibitor Opdivo, for a variety of solid tumors.</p>\n<p>As things stand now, Mereo's anti-TIGIT candidate is slated to yield top-line data from this basket trial in approximately 18-months from now. During this lengthy interval, however, the drugmaker ought to provide multiple updates on etigilimab's progress, which could turn out to be a series of major catalysts for its share price in the coming months. Another bit of good news is that Mereo's cash runway reportedly extends into 2024. That's key, because it means that the biotech shouldn't have to repeatly tap the public markets for capital over the next year and a half.</p>\n<p>What's the downside risk? Mereo's management team has been open about its desire to partner with larger biopharmas. Etigilimab, for its part, could spark either a high dollar licensing agreement or a full-on buyout within the next two years. So a lot is riding on this single experimental drug. Unfortunately, early stage cancer therapies fail more often than not in the clinic. As a failure in this case would weigh heavily on the biotech's share price, potential investors may want to keep any initial position on the small side.</p>\n<p><b>Senseonic: A rising tide lifts all boats</b></p>\n<p>Senseonics' stock is worth a look by ultra-aggressive investors due to its implantable continuous glucose monitoring (CGM) device franchise known as Eversense. The lowdown is that the CGM market has been growing by over 10%&nbsp;<i>per year</i>&nbsp;over the past five years, according to a report by Grand View Research. What's more, this space is forecast to grow by at least 10% per year over the next five years. That's definitely a favorable trend for a small-cap CGM player like Senseonics.</p>\n<p>So far, Senseonics has only captured a&nbsp;small sliver&nbsp;of this multi-billion dollar medical device market with its Eversense franchise. But the company is hoping to drastically improve its competitive positioning with a potential regulatory approval by the Food and Drug Administration (FDA) for its 180-day version of the Eversense CGM system. The medical device company&nbsp;submitteda regulatory application to the FDA for this proposed product over a year ago. So a decision could come any day now.</p>\n<p>Why does this FDA approval matter? Senseonics' internal projections have the company's top-line rising at a compound annual growth rate of over 70% over the next five years as a result of this key regulatory nod. The long and short of it is that the current 90-day Eversense CGM system isn't particularly competitive in the U.S. against the market-leading devices from&nbsp;<b>DexCom</b>&nbsp;and&nbsp;<b>Abbott Laboratories</b>, respectively. But this longer-lasting version of the device could cause sales to skyrocket in the coming years.</p>\n<p>What's the risk? Senseonics is competing in a jam-packed space against a number of well-capitalized medical-device giants. So there is a chance that this long-awaited FDA approval won't spark a parabolic rise in sales. That's not a knock against Senseonics' CGM system, but rather the harsh reality of competing against healthcare companies with vastly superior resources. Investors shouldn't ignore this potential risk factor.</p>\n<p>All told, Senseonics could be on the verge of a game-changing regulatory event that might prove to be a key inflection point for the company's CGM franchise. If true, this medical device company's stock should turn out to be a downright bargain at these levels.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Growth Stocks That Could Deliver 1,000% Returns</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Growth Stocks That Could Deliver 1,000% Returns\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-01 11:14 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/10/31/2-growth-stocks-that-could-deliver-1000-returns/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Thanks to the ongoing innovation revolutions in both the tech and healthcare sectors, shareholders have been enjoying historic returns on capital over the past decade. For example, the central nervous...</p>\n\n<a href=\"https://www.fool.com/investing/2021/10/31/2-growth-stocks-that-could-deliver-1000-returns/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MREO":"Mereo Biopharma Group Plc","SENS":"Senseonics Holdings,Inc."},"source_url":"https://www.fool.com/investing/2021/10/31/2-growth-stocks-that-could-deliver-1000-returns/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1164035523","content_text":"Thanks to the ongoing innovation revolutions in both the tech and healthcare sectors, shareholders have been enjoying historic returns on capital over the past decade. For example, the central nervous system disorder drug specialist Axsome Therapeutics, the cancer specialist Exelixis, and the electric car pioneer Tesla have all delivered tenfold returns for investors who bought these names at their low points.\nWhich stocks might be the next Axsome, Exelixis, or Tesla from a growth standpoint? The cancer/rare disease specialist Mereo BioPharma Group(NASDAQ:MREO)and the diabetes-focused medical device company Senseonics Holdings(NYSEMKT:SENS)could both be gearing up for a monstrous run higher soon. In fact, these two low-priced healthcare stocks have a decent shot at generating 1,000%-plus returns for their shareholders within the next two to three years.\nHere's a brief overview on the risks and potential rewards associated with each of these promising growth vehicles.\nMereo BioPharma: A bet on the future of immunotherapy\nThe London-based biopharma Mereo hasn't exactly set the world on fire since its American depository shares (ADS) made their debut on the Nasdaq stock exchange. Keeping with this theme, the biotech's ADSes have lost approximately 65% of their value since April 2019. This steady downward trend shouldn't scare away aggressive investors, however. Mereo's plunging share price, after all, is more about Mr. Market's well-known impatience with clinical-stage biotechs, rather than the company's underlying value proposition.\nWhat's the scoop? Mereo is a small-cap company with six assets under development for both cancer and rare diseases. However, the one drug candidate that could undoubtedly send the company's shares rocketing higher is the anti-TIGIT therapy known as etigilimab. Several major drug companies, such as BeiGene,Bristol Myers Squibb,Merck, and Roche, have anti-TIGIT therapies under development due to their potential to boost the efficacy and durability of cancer immunotherapy treatments in general. Mereo's etigilimab is currently in a combined phase 1/2 basket study to evaluate its utility as part of combination treament, along with Bristol's megablockbuster checkpoint inhibitor Opdivo, for a variety of solid tumors.\nAs things stand now, Mereo's anti-TIGIT candidate is slated to yield top-line data from this basket trial in approximately 18-months from now. During this lengthy interval, however, the drugmaker ought to provide multiple updates on etigilimab's progress, which could turn out to be a series of major catalysts for its share price in the coming months. Another bit of good news is that Mereo's cash runway reportedly extends into 2024. That's key, because it means that the biotech shouldn't have to repeatly tap the public markets for capital over the next year and a half.\nWhat's the downside risk? Mereo's management team has been open about its desire to partner with larger biopharmas. Etigilimab, for its part, could spark either a high dollar licensing agreement or a full-on buyout within the next two years. So a lot is riding on this single experimental drug. Unfortunately, early stage cancer therapies fail more often than not in the clinic. As a failure in this case would weigh heavily on the biotech's share price, potential investors may want to keep any initial position on the small side.\nSenseonic: A rising tide lifts all boats\nSenseonics' stock is worth a look by ultra-aggressive investors due to its implantable continuous glucose monitoring (CGM) device franchise known as Eversense. The lowdown is that the CGM market has been growing by over 10% per year over the past five years, according to a report by Grand View Research. What's more, this space is forecast to grow by at least 10% per year over the next five years. That's definitely a favorable trend for a small-cap CGM player like Senseonics.\nSo far, Senseonics has only captured a small sliver of this multi-billion dollar medical device market with its Eversense franchise. But the company is hoping to drastically improve its competitive positioning with a potential regulatory approval by the Food and Drug Administration (FDA) for its 180-day version of the Eversense CGM system. The medical device company submitteda regulatory application to the FDA for this proposed product over a year ago. So a decision could come any day now.\nWhy does this FDA approval matter? Senseonics' internal projections have the company's top-line rising at a compound annual growth rate of over 70% over the next five years as a result of this key regulatory nod. The long and short of it is that the current 90-day Eversense CGM system isn't particularly competitive in the U.S. against the market-leading devices from DexCom and Abbott Laboratories, respectively. But this longer-lasting version of the device could cause sales to skyrocket in the coming years.\nWhat's the risk? Senseonics is competing in a jam-packed space against a number of well-capitalized medical-device giants. So there is a chance that this long-awaited FDA approval won't spark a parabolic rise in sales. That's not a knock against Senseonics' CGM system, but rather the harsh reality of competing against healthcare companies with vastly superior resources. Investors shouldn't ignore this potential risk factor.\nAll told, Senseonics could be on the verge of a game-changing regulatory event that might prove to be a key inflection point for the company's CGM franchise. If true, this medical device company's stock should turn out to be a downright bargain at these levels.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1093,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":164993620,"gmtCreate":1624164144060,"gmtModify":1634009935589,"author":{"id":"3574933488250733","authorId":"3574933488250733","name":"DoubleClick","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574933488250733","authorIdStr":"3574933488250733"},"themes":[],"htmlText":"Latest","listText":"Latest","text":"Latest","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/164993620","repostId":"1126454279","repostType":2,"isVote":1,"tweetType":1,"viewCount":95,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":878020564,"gmtCreate":1637126588784,"gmtModify":1637126588955,"author":{"id":"3574933488250733","authorId":"3574933488250733","name":"DoubleClick","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574933488250733","authorIdStr":"3574933488250733"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/IQ\">$iQiyi Inc.(IQ)$</a>For long term play? 💎✊🏻","listText":"<a href=\"https://laohu8.com/S/IQ\">$iQiyi Inc.(IQ)$</a>For long term play? 💎✊🏻","text":"$iQiyi Inc.(IQ)$For long term play? 💎✊🏻","images":[{"img":"https://static.tigerbbs.com/bf5a60bc4debb04026b17b9cdc2ecc62","width":"750","height":"2443"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":11,"repostSize":0,"link":"https://laohu8.com/post/878020564","isVote":1,"tweetType":1,"viewCount":901,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":872837844,"gmtCreate":1637471088221,"gmtModify":1637471088326,"author":{"id":"3574933488250733","authorId":"3574933488250733","name":"DoubleClick","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574933488250733","authorIdStr":"3574933488250733"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>Ride the upward momentum!","listText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>Ride the upward momentum!","text":"$Apple(AAPL)$Ride the upward momentum!","images":[{"img":"https://static.tigerbbs.com/5fa407a19830d6fd52b2503f25ec1c6b","width":"750","height":"2298"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/872837844","isVote":1,"tweetType":1,"viewCount":1324,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":870345013,"gmtCreate":1636590325446,"gmtModify":1636590325446,"author":{"id":"3574933488250733","authorId":"3574933488250733","name":"DoubleClick","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574933488250733","authorIdStr":"3574933488250733"},"themes":[],"htmlText":"Lol need more words in the thesaurus for “drop”.&nbsp;","listText":"Lol need more words in the thesaurus for “drop”.&nbsp;","text":"Lol need more words in the thesaurus for “drop”.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/870345013","repostId":"1163617251","repostType":2,"repost":{"id":"1163617251","kind":"news","pubTimestamp":1636589713,"share":"https://www.laohu8.com/m/news/1163617251?lang=&edition=full","pubTime":"2021-11-11 08:15","market":"sg","language":"en","title":"Continued Consolidation Called For Singapore Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1163617251","media":"RTTNews","summary":"(RTTNews) - The Singapore stock market has finished lower in two straight sessions, dropping more th","content":"<p>(RTTNews) - The Singapore stock market has finished lower in two straight sessions, dropping more than 30 points or 1 percent along the way. The Straits Times Index now sits just above the 3,230-point plateau and it may extend its losses on Thursday.</p>\n<p>The global forecast for the Asian markets suggests consolidation on inflation concerns and a drop in crude oil prices. The European markets were up and the U.S. bourses were down and the Asian markets figure to follow the latter lead.</p>\n<p>The STI finished modestly lower on Wednesday following losses from the financial shares, property stocks and industrial issues.</p>\n<p>For the day, the index shed 12.10 points or 0.37 percent to finish at 3,231.32 after trading between 3,218.31 and 3,246.00. Volume was 2.03 billion shares worth 1.05 billion Singapore dollars. There were 256 decliners and 204 gainers.</p>\n<p>Among the actives, Ascendas REIT fell 0.32 percent, while <a href=\"https://laohu8.com/S/CHCO\">City</a> Developments rose 0.28 percent, Comfort DelGro and DBS Group both skidded 0.62 percent, Dairy Farm International plummeted 1.17 percent, Jardine Cycle advanced 1.02 percent, Jardine Matheson climbed 1.16 percent, Mapletree Commercial Trust dropped 0.47 percent, Mapletree Logistics Trust sank 0.51 percent, Oversea-Chinese Banking Corporation lost 0.34 percent, SATS surrendered 0.95 percent, SembCorp Industries tumbled 0.96 percent, Singapore Airlines tanked 1.09 percent, Singapore Exchange eased 0.21 percent, Singapore Technologies Engineering gained 0.79 percent, SingTel declined 0.78 percent, <a href=\"https://laohu8.com/S/UBNK\">United</a> Overseas Bank retreated 0.75 percent, Wilmar International plunged 1.14 percent, Yangzijiang Shipbuilding added 0.80 percent and Keppel Corp, Genting Singapore, CapitaLand, CapitaLand Integrated Commercial Trust, Thai Beverage and Singapore Press Holdings were unchanged.</p>\n<p>The lead from Wall Street is broadly negative as the major averages opened slightly lower on Wednesday but saw the losses accelerate as the day progressed to finish solidly under water.</p>\n<p>The Dow tumbled 240.04 points or 0.66 percent to finish at 36,079.94, while the NASDAQ plunged 263.84 points or 1.66 percent to close at 15,622.71 and the S&amp;P 500 sank 38.54 points or 0.82 percent to end at 4,646.71.</p>\n<p>Concerns about inflation contributed to the weakness on Wall Street after the Labor Department released a report showing consumer prices increased by more than expected in October, lifting the annual rate of price growth to its highest level in over thirty years.</p>\n<p>The acceleration in the rate of consumer price inflation raised concerns about the outlook for interest rates even though the Federal Reserve has signaled it will not be in a hurry to begin raising rates.</p>\n<p>Also, a separate report from the Labor Department showed another modest decrease in first-time claims for U.S. unemployment benefits last week.</p>\n<p>Crude oil prices declined sharply on Wednesday, snapping a three-day winning streak after data showed an increase in U.S. crude stockpiles last week. <a href=\"https://laohu8.com/S/WSTC\">West</a> Texas Intermediate Crude oil futures for December ended down by $2.81 or 3.3 percent at $81.34 a barrel.</p>","source":"lsy1603171495471","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Continued Consolidation Called For Singapore Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nContinued Consolidation Called For Singapore Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-11 08:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.nasdaq.com/articles/continued-consolidation-called-for-singapore-shares><strong>RTTNews</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(RTTNews) - The Singapore stock market has finished lower in two straight sessions, dropping more than 30 points or 1 percent along the way. The Straits Times Index now sits just above the 3,230-point...</p>\n\n<a href=\"https://www.nasdaq.com/articles/continued-consolidation-called-for-singapore-shares\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.nasdaq.com/articles/continued-consolidation-called-for-singapore-shares","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1163617251","content_text":"(RTTNews) - The Singapore stock market has finished lower in two straight sessions, dropping more than 30 points or 1 percent along the way. The Straits Times Index now sits just above the 3,230-point plateau and it may extend its losses on Thursday.\nThe global forecast for the Asian markets suggests consolidation on inflation concerns and a drop in crude oil prices. The European markets were up and the U.S. bourses were down and the Asian markets figure to follow the latter lead.\nThe STI finished modestly lower on Wednesday following losses from the financial shares, property stocks and industrial issues.\nFor the day, the index shed 12.10 points or 0.37 percent to finish at 3,231.32 after trading between 3,218.31 and 3,246.00. Volume was 2.03 billion shares worth 1.05 billion Singapore dollars. There were 256 decliners and 204 gainers.\nAmong the actives, Ascendas REIT fell 0.32 percent, while City Developments rose 0.28 percent, Comfort DelGro and DBS Group both skidded 0.62 percent, Dairy Farm International plummeted 1.17 percent, Jardine Cycle advanced 1.02 percent, Jardine Matheson climbed 1.16 percent, Mapletree Commercial Trust dropped 0.47 percent, Mapletree Logistics Trust sank 0.51 percent, Oversea-Chinese Banking Corporation lost 0.34 percent, SATS surrendered 0.95 percent, SembCorp Industries tumbled 0.96 percent, Singapore Airlines tanked 1.09 percent, Singapore Exchange eased 0.21 percent, Singapore Technologies Engineering gained 0.79 percent, SingTel declined 0.78 percent, United Overseas Bank retreated 0.75 percent, Wilmar International plunged 1.14 percent, Yangzijiang Shipbuilding added 0.80 percent and Keppel Corp, Genting Singapore, CapitaLand, CapitaLand Integrated Commercial Trust, Thai Beverage and Singapore Press Holdings were unchanged.\nThe lead from Wall Street is broadly negative as the major averages opened slightly lower on Wednesday but saw the losses accelerate as the day progressed to finish solidly under water.\nThe Dow tumbled 240.04 points or 0.66 percent to finish at 36,079.94, while the NASDAQ plunged 263.84 points or 1.66 percent to close at 15,622.71 and the S&P 500 sank 38.54 points or 0.82 percent to end at 4,646.71.\nConcerns about inflation contributed to the weakness on Wall Street after the Labor Department released a report showing consumer prices increased by more than expected in October, lifting the annual rate of price growth to its highest level in over thirty years.\nThe acceleration in the rate of consumer price inflation raised concerns about the outlook for interest rates even though the Federal Reserve has signaled it will not be in a hurry to begin raising rates.\nAlso, a separate report from the Labor Department showed another modest decrease in first-time claims for U.S. unemployment benefits last week.\nCrude oil prices declined sharply on Wednesday, snapping a three-day winning streak after data showed an increase in U.S. crude stockpiles last week. West Texas Intermediate Crude oil futures for December ended down by $2.81 or 3.3 percent at $81.34 a barrel.","news_type":1},"isVote":1,"tweetType":1,"viewCount":977,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":873789420,"gmtCreate":1636987209261,"gmtModify":1636987209401,"author":{"id":"3574933488250733","authorId":"3574933488250733","name":"DoubleClick","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574933488250733","authorIdStr":"3574933488250733"},"themes":[],"htmlText":"Here for the coins!","listText":"Here for the coins!","text":"Here for the coins!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/873789420","repostId":"873287761","repostType":1,"repost":{"id":873287761,"gmtCreate":1636948480350,"gmtModify":1636957657847,"author":{"id":"3527667583497005","authorId":"3527667583497005","name":"期权异动观察","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3527667583497005","authorIdStr":"3527667583497005"},"themes":[],"title":"11.15期权异动观察，AMD反复异动","htmlText":"<a target=\"_blank\" href=\"https://laohu8.com/S/ACB\">$奥罗拉大麻公司(ACB)$</a>&nbsp;在<a target=\"_blank\" href=\"https://laohu8.com/S/SNDL\">$Sundial Growers Inc.(SNDL)$</a> 的带动下，周五大麻股出现了集体异动，ACB公司评级获得了部分评级机构上调，后续走势看大麻bank整体走势。坎托菲茨杰拉德公司：维持Aurora Cannabis Inc(ACB.US)中性评级, 目标价由9.60美元调整至10.75美元。 <a target=\"_blank\" href=\"https://laohu8.com/S/AMD\">$AMD(AMD)$</a> 最近股价频繁异动，消息面趋于平静，股价依然处于强势状态。 <a target=\"_blank\" href=\"https://laohu8.com/S/ATVI\">$动视暴雪(ATVI)$</a>财报不及预期暴跌之后，最近走稳开始向上拉升， 消息面平静。 <a target=\"_blank\" href=\"https://laohu8.com/S/TTD\">$Trade Desk Inc.(TTD)$</a>最近也是二次异动，该股依然处于强势上攻，奥本海默在11.9日将公司的目标价从95美元上调至100美元。 <a target=\"_blank\" href=\"https://laohu8.com/S/TSLA\">$特斯拉(TSLA)$</a> 上周下跌15%，马斯克持续减持股份，短期走势看震荡，目测这个月马斯克就可以将手里的股份减持完毕。 <a href=\"https://laohu8.com/TW/854739948\" target=\"_blank\">目前模拟账户也已经上线了期权交易功能，</a>","listText":"<a target=\"_blank\" href=\"https://laohu8.com/S/ACB\">$奥罗拉大麻公司(ACB)$</a>&nbsp;在<a target=\"_blank\" href=\"https://laohu8.com/S/SNDL\">$Sundial Growers Inc.(SNDL)$</a> 的带动下，周五大麻股出现了集体异动，ACB公司评级获得了部分评级机构上调，后续走势看大麻bank整体走势。坎托菲茨杰拉德公司：维持Aurora Cannabis Inc(ACB.US)中性评级, 目标价由9.60美元调整至10.75美元。 <a target=\"_blank\" href=\"https://laohu8.com/S/AMD\">$AMD(AMD)$</a> 最近股价频繁异动，消息面趋于平静，股价依然处于强势状态。 <a target=\"_blank\" href=\"https://laohu8.com/S/ATVI\">$动视暴雪(ATVI)$</a>财报不及预期暴跌之后，最近走稳开始向上拉升， 消息面平静。 <a target=\"_blank\" href=\"https://laohu8.com/S/TTD\">$Trade Desk Inc.(TTD)$</a>最近也是二次异动，该股依然处于强势上攻，奥本海默在11.9日将公司的目标价从95美元上调至100美元。 <a target=\"_blank\" href=\"https://laohu8.com/S/TSLA\">$特斯拉(TSLA)$</a> 上周下跌15%，马斯克持续减持股份，短期走势看震荡，目测这个月马斯克就可以将手里的股份减持完毕。 <a href=\"https://laohu8.com/TW/854739948\" target=\"_blank\">目前模拟账户也已经上线了期权交易功能，</a>","text":"$奥罗拉大麻公司(ACB)$ 在$Sundial Growers Inc.(SNDL)$ 的带动下，周五大麻股出现了集体异动，ACB公司评级获得了部分评级机构上调，后续走势看大麻bank整体走势。坎托菲茨杰拉德公司：维持Aurora Cannabis Inc(ACB.US)中性评级, 目标价由9.60美元调整至10.75美元。 $AMD(AMD)$ 最近股价频繁异动，消息面趋于平静，股价依然处于强势状态。 $动视暴雪(ATVI)$财报不及预期暴跌之后，最近走稳开始向上拉升， 消息面平静。 $Trade Desk Inc.(TTD)$最近也是二次异动，该股依然处于强势上攻，奥本海默在11.9日将公司的目标价从95美元上调至100美元。 $特斯拉(TSLA)$ 上周下跌15%，马斯克持续减持股份，短期走势看震荡，目测这个月马斯克就可以将手里的股份减持完毕。 目前模拟账户也已经上线了期权交易功能，","images":[{"img":"https://static.tigerbbs.com/913d99ad732154469e49fa9467361f77","width":"799","height":"698"}],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/873287761","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":743,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":848639075,"gmtCreate":1635993150614,"gmtModify":1635993150735,"author":{"id":"3574933488250733","authorId":"3574933488250733","name":"DoubleClick","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574933488250733","authorIdStr":"3574933488250733"},"themes":[],"htmlText":"Happy Diwali Everyone!&nbsp;","listText":"Happy Diwali Everyone!&nbsp;","text":"Happy Diwali Everyone!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/848639075","isVote":1,"tweetType":1,"viewCount":936,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":849880046,"gmtCreate":1635741983209,"gmtModify":1635741983209,"author":{"id":"3574933488250733","authorId":"3574933488250733","name":"DoubleClick","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574933488250733","authorIdStr":"3574933488250733"},"themes":[],"htmlText":"Nice!","listText":"Nice!","text":"Nice!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/849880046","repostId":"1164035523","repostType":2,"repost":{"id":"1164035523","kind":"news","pubTimestamp":1635736469,"share":"https://www.laohu8.com/m/news/1164035523?lang=&edition=full","pubTime":"2021-11-01 11:14","market":"us","language":"en","title":"2 Growth Stocks That Could Deliver 1,000% Returns","url":"https://stock-news.laohu8.com/highlight/detail?id=1164035523","media":"Motley Fool","summary":"Thanks to the ongoing innovation revolutions in both the tech and healthcare sectors, shareholders h","content":"<p>Thanks to the ongoing innovation revolutions in both the tech and healthcare sectors, shareholders have been enjoying historic returns on capital over the past decade. For example, the central nervous system disorder drug specialist&nbsp;<b>Axsome Therapeutics</b>, the cancer specialist&nbsp;<b>Exelixis</b>, and the electric car pioneer&nbsp;<b>Tesla</b>&nbsp;have all delivered tenfold returns for investors who bought these names at their low points.</p>\n<p>Which stocks might be the next Axsome, Exelixis, or Tesla from a growth standpoint? The cancer/rare disease specialist&nbsp;<b>Mereo BioPharma Group</b>(NASDAQ:MREO)and the diabetes-focused medical device company&nbsp;<b>Senseonics Holdings</b>(NYSEMKT:SENS)could both be gearing up for a monstrous run higher soon. In fact, these two low-priced&nbsp;healthcare stocks&nbsp;have a decent shot at generating 1,000%-plus returns for their shareholders within the next two to three years.</p>\n<p>Here's a brief overview on the risks and potential rewards associated with each of these promising growth vehicles.</p>\n<p><b>Mereo BioPharma: A bet on the future of immunotherapy</b></p>\n<p>The London-based biopharma Mereo hasn't exactly set the world on fire since its American depository shares (ADS) made their debut on the Nasdaq stock exchange. Keeping with this theme, the biotech's ADSes have lost approximately 65% of their value since April 2019. This steady downward trend shouldn't scare away aggressive investors, however. Mereo's plunging share price, after all, is more about Mr. Market's well-known impatience with clinical-stage biotechs, rather than the company's underlying value proposition.</p>\n<p>What's the scoop? Mereo is a small-cap company with six assets under development for both cancer and rare diseases. However, the one drug candidate that could undoubtedly send the company's shares rocketing higher is the&nbsp;anti-TIGIT therapy&nbsp;known as etigilimab. Several major drug companies, such as&nbsp;<b>BeiGene</b>,<b>Bristol Myers Squibb</b>,<b>Merck</b>, and&nbsp;<b>Roche</b>, have anti-TIGIT therapies under development due to their potential to boost the efficacy and durability of cancer immunotherapy treatments in general. Mereo's etigilimab is currently in a combined phase 1/2 basket study to evaluate its utility as part of combination treament, along with Bristol's megablockbuster checkpoint inhibitor Opdivo, for a variety of solid tumors.</p>\n<p>As things stand now, Mereo's anti-TIGIT candidate is slated to yield top-line data from this basket trial in approximately 18-months from now. During this lengthy interval, however, the drugmaker ought to provide multiple updates on etigilimab's progress, which could turn out to be a series of major catalysts for its share price in the coming months. Another bit of good news is that Mereo's cash runway reportedly extends into 2024. That's key, because it means that the biotech shouldn't have to repeatly tap the public markets for capital over the next year and a half.</p>\n<p>What's the downside risk? Mereo's management team has been open about its desire to partner with larger biopharmas. Etigilimab, for its part, could spark either a high dollar licensing agreement or a full-on buyout within the next two years. So a lot is riding on this single experimental drug. Unfortunately, early stage cancer therapies fail more often than not in the clinic. As a failure in this case would weigh heavily on the biotech's share price, potential investors may want to keep any initial position on the small side.</p>\n<p><b>Senseonic: A rising tide lifts all boats</b></p>\n<p>Senseonics' stock is worth a look by ultra-aggressive investors due to its implantable continuous glucose monitoring (CGM) device franchise known as Eversense. The lowdown is that the CGM market has been growing by over 10%&nbsp;<i>per year</i>&nbsp;over the past five years, according to a report by Grand View Research. What's more, this space is forecast to grow by at least 10% per year over the next five years. That's definitely a favorable trend for a small-cap CGM player like Senseonics.</p>\n<p>So far, Senseonics has only captured a&nbsp;small sliver&nbsp;of this multi-billion dollar medical device market with its Eversense franchise. But the company is hoping to drastically improve its competitive positioning with a potential regulatory approval by the Food and Drug Administration (FDA) for its 180-day version of the Eversense CGM system. The medical device company&nbsp;submitteda regulatory application to the FDA for this proposed product over a year ago. So a decision could come any day now.</p>\n<p>Why does this FDA approval matter? Senseonics' internal projections have the company's top-line rising at a compound annual growth rate of over 70% over the next five years as a result of this key regulatory nod. The long and short of it is that the current 90-day Eversense CGM system isn't particularly competitive in the U.S. against the market-leading devices from&nbsp;<b>DexCom</b>&nbsp;and&nbsp;<b>Abbott Laboratories</b>, respectively. But this longer-lasting version of the device could cause sales to skyrocket in the coming years.</p>\n<p>What's the risk? Senseonics is competing in a jam-packed space against a number of well-capitalized medical-device giants. So there is a chance that this long-awaited FDA approval won't spark a parabolic rise in sales. That's not a knock against Senseonics' CGM system, but rather the harsh reality of competing against healthcare companies with vastly superior resources. Investors shouldn't ignore this potential risk factor.</p>\n<p>All told, Senseonics could be on the verge of a game-changing regulatory event that might prove to be a key inflection point for the company's CGM franchise. If true, this medical device company's stock should turn out to be a downright bargain at these levels.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Growth Stocks That Could Deliver 1,000% Returns</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Growth Stocks That Could Deliver 1,000% Returns\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-01 11:14 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/10/31/2-growth-stocks-that-could-deliver-1000-returns/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Thanks to the ongoing innovation revolutions in both the tech and healthcare sectors, shareholders have been enjoying historic returns on capital over the past decade. For example, the central nervous...</p>\n\n<a href=\"https://www.fool.com/investing/2021/10/31/2-growth-stocks-that-could-deliver-1000-returns/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MREO":"Mereo Biopharma Group Plc","SENS":"Senseonics Holdings,Inc."},"source_url":"https://www.fool.com/investing/2021/10/31/2-growth-stocks-that-could-deliver-1000-returns/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1164035523","content_text":"Thanks to the ongoing innovation revolutions in both the tech and healthcare sectors, shareholders have been enjoying historic returns on capital over the past decade. For example, the central nervous system disorder drug specialist Axsome Therapeutics, the cancer specialist Exelixis, and the electric car pioneer Tesla have all delivered tenfold returns for investors who bought these names at their low points.\nWhich stocks might be the next Axsome, Exelixis, or Tesla from a growth standpoint? The cancer/rare disease specialist Mereo BioPharma Group(NASDAQ:MREO)and the diabetes-focused medical device company Senseonics Holdings(NYSEMKT:SENS)could both be gearing up for a monstrous run higher soon. In fact, these two low-priced healthcare stocks have a decent shot at generating 1,000%-plus returns for their shareholders within the next two to three years.\nHere's a brief overview on the risks and potential rewards associated with each of these promising growth vehicles.\nMereo BioPharma: A bet on the future of immunotherapy\nThe London-based biopharma Mereo hasn't exactly set the world on fire since its American depository shares (ADS) made their debut on the Nasdaq stock exchange. Keeping with this theme, the biotech's ADSes have lost approximately 65% of their value since April 2019. This steady downward trend shouldn't scare away aggressive investors, however. Mereo's plunging share price, after all, is more about Mr. Market's well-known impatience with clinical-stage biotechs, rather than the company's underlying value proposition.\nWhat's the scoop? Mereo is a small-cap company with six assets under development for both cancer and rare diseases. However, the one drug candidate that could undoubtedly send the company's shares rocketing higher is the anti-TIGIT therapy known as etigilimab. Several major drug companies, such as BeiGene,Bristol Myers Squibb,Merck, and Roche, have anti-TIGIT therapies under development due to their potential to boost the efficacy and durability of cancer immunotherapy treatments in general. Mereo's etigilimab is currently in a combined phase 1/2 basket study to evaluate its utility as part of combination treament, along with Bristol's megablockbuster checkpoint inhibitor Opdivo, for a variety of solid tumors.\nAs things stand now, Mereo's anti-TIGIT candidate is slated to yield top-line data from this basket trial in approximately 18-months from now. During this lengthy interval, however, the drugmaker ought to provide multiple updates on etigilimab's progress, which could turn out to be a series of major catalysts for its share price in the coming months. Another bit of good news is that Mereo's cash runway reportedly extends into 2024. That's key, because it means that the biotech shouldn't have to repeatly tap the public markets for capital over the next year and a half.\nWhat's the downside risk? Mereo's management team has been open about its desire to partner with larger biopharmas. Etigilimab, for its part, could spark either a high dollar licensing agreement or a full-on buyout within the next two years. So a lot is riding on this single experimental drug. Unfortunately, early stage cancer therapies fail more often than not in the clinic. As a failure in this case would weigh heavily on the biotech's share price, potential investors may want to keep any initial position on the small side.\nSenseonic: A rising tide lifts all boats\nSenseonics' stock is worth a look by ultra-aggressive investors due to its implantable continuous glucose monitoring (CGM) device franchise known as Eversense. The lowdown is that the CGM market has been growing by over 10% per year over the past five years, according to a report by Grand View Research. What's more, this space is forecast to grow by at least 10% per year over the next five years. That's definitely a favorable trend for a small-cap CGM player like Senseonics.\nSo far, Senseonics has only captured a small sliver of this multi-billion dollar medical device market with its Eversense franchise. But the company is hoping to drastically improve its competitive positioning with a potential regulatory approval by the Food and Drug Administration (FDA) for its 180-day version of the Eversense CGM system. The medical device company submitteda regulatory application to the FDA for this proposed product over a year ago. So a decision could come any day now.\nWhy does this FDA approval matter? Senseonics' internal projections have the company's top-line rising at a compound annual growth rate of over 70% over the next five years as a result of this key regulatory nod. The long and short of it is that the current 90-day Eversense CGM system isn't particularly competitive in the U.S. against the market-leading devices from DexCom and Abbott Laboratories, respectively. But this longer-lasting version of the device could cause sales to skyrocket in the coming years.\nWhat's the risk? Senseonics is competing in a jam-packed space against a number of well-capitalized medical-device giants. So there is a chance that this long-awaited FDA approval won't spark a parabolic rise in sales. That's not a knock against Senseonics' CGM system, but rather the harsh reality of competing against healthcare companies with vastly superior resources. Investors shouldn't ignore this potential risk factor.\nAll told, Senseonics could be on the verge of a game-changing regulatory event that might prove to be a key inflection point for the company's CGM franchise. If true, this medical device company's stock should turn out to be a downright bargain at these levels.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1093,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":164993620,"gmtCreate":1624164144060,"gmtModify":1634009935589,"author":{"id":"3574933488250733","authorId":"3574933488250733","name":"DoubleClick","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574933488250733","authorIdStr":"3574933488250733"},"themes":[],"htmlText":"Latest","listText":"Latest","text":"Latest","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/164993620","repostId":"1126454279","repostType":2,"isVote":1,"tweetType":1,"viewCount":95,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":874477757,"gmtCreate":1637818653179,"gmtModify":1637818653328,"author":{"id":"3574933488250733","authorId":"3574933488250733","name":"DoubleClick","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574933488250733","authorIdStr":"3574933488250733"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/IQ\">$iQiyi Inc.(IQ)$</a> 是我的第一次","listText":"<a href=\"https://laohu8.com/S/IQ\">$iQiyi Inc.(IQ)$</a> 是我的第一次","text":"$iQiyi Inc.(IQ)$ 是我的第一次","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/874477757","repostId":"875266611","repostType":1,"repost":{"id":875266611,"gmtCreate":1637659026330,"gmtModify":1637929617182,"author":{"id":"36984908995200","authorId":"36984908995200","name":"小虎活动","avatar":"https://static.tigerbbs.com/9e396d03155923b283948d2dec9191f8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"36984908995200","authorIdStr":"36984908995200"},"themes":[],"title":"【感恩回馈】说说你和老虎的第一次","htmlText":"感恩节马上要到了，小虎提醒：感恩节周四(11月25日)美股休市哦！感恩节翌日(26日)美股提前3小时收盘~ 为了回馈广大虎友们的支持与陪伴，小虎君为大家准备了一些小礼物，参与即可获赠66虎币，如果你愿意多聊2句，还有机会获得小虎全套盲盒。 不知不觉，老虎已经成立7年了， 在过去年的7年，我们认识了很多新老朋友 可曾记得你是何时加入老虎的？ 又是缘何来到这里？ 【参与方式】 本帖留言说出 「你和老虎的第一次」 你发布的第一个帖子是什么？ 你关注的第一个好友是谁？ 你关注/交易的第一只股票是什么？ 【活动奖励】 凡是参与晒单的虎友均可获得66虎币，除此之外，还有机会获得以下奖励： 知己奖：我们会选取“第一条帖子”发帖时间最早的虎友赠予1套小虎盲盒手办（5个） 人气奖：我们会选取评论获赞量最高的3位虎友，随机赠予小虎盲盒手办1个 优质奖：我们会随机选取评论优质有趣的虎友，随机赠予小虎盲盒手办1个 【活动时间】： 2021年11月23日-11月29日 【特别说明】 水贴，重复内容，广告，恶意营销等属于无效内容； 文章需原创并首发于老虎，并且版权归老虎社区所有； 本次活动中用户所提到的标的，仅供参考，不构成投资建议，据此操作，风险自负； 活动最终解释权归老虎社区所有； 若对本次活动有不解之处，可在此贴留言，或微信虎妞（微信号：itiger2014）咨询。 欢迎大家在下贴评论区留言说说「你和老虎的第一次」，你发布的第一个帖子是什么？你关注的第一个好友是谁？你关注/交易的第一只股票是什么？参与即可获赠66虎币，如果你愿意多聊2句，还有机会获得小虎全套盲盒。","listText":"感恩节马上要到了，小虎提醒：感恩节周四(11月25日)美股休市哦！感恩节翌日(26日)美股提前3小时收盘~ 为了回馈广大虎友们的支持与陪伴，小虎君为大家准备了一些小礼物，参与即可获赠66虎币，如果你愿意多聊2句，还有机会获得小虎全套盲盒。 不知不觉，老虎已经成立7年了， 在过去年的7年，我们认识了很多新老朋友 可曾记得你是何时加入老虎的？ 又是缘何来到这里？ 【参与方式】 本帖留言说出 「你和老虎的第一次」 你发布的第一个帖子是什么？ 你关注的第一个好友是谁？ 你关注/交易的第一只股票是什么？ 【活动奖励】 凡是参与晒单的虎友均可获得66虎币，除此之外，还有机会获得以下奖励： 知己奖：我们会选取“第一条帖子”发帖时间最早的虎友赠予1套小虎盲盒手办（5个） 人气奖：我们会选取评论获赞量最高的3位虎友，随机赠予小虎盲盒手办1个 优质奖：我们会随机选取评论优质有趣的虎友，随机赠予小虎盲盒手办1个 【活动时间】： 2021年11月23日-11月29日 【特别说明】 水贴，重复内容，广告，恶意营销等属于无效内容； 文章需原创并首发于老虎，并且版权归老虎社区所有； 本次活动中用户所提到的标的，仅供参考，不构成投资建议，据此操作，风险自负； 活动最终解释权归老虎社区所有； 若对本次活动有不解之处，可在此贴留言，或微信虎妞（微信号：itiger2014）咨询。 欢迎大家在下贴评论区留言说说「你和老虎的第一次」，你发布的第一个帖子是什么？你关注的第一个好友是谁？你关注/交易的第一只股票是什么？参与即可获赠66虎币，如果你愿意多聊2句，还有机会获得小虎全套盲盒。","text":"感恩节马上要到了，小虎提醒：感恩节周四(11月25日)美股休市哦！感恩节翌日(26日)美股提前3小时收盘~ 为了回馈广大虎友们的支持与陪伴，小虎君为大家准备了一些小礼物，参与即可获赠66虎币，如果你愿意多聊2句，还有机会获得小虎全套盲盒。 不知不觉，老虎已经成立7年了， 在过去年的7年，我们认识了很多新老朋友 可曾记得你是何时加入老虎的？ 又是缘何来到这里？ 【参与方式】 本帖留言说出 「你和老虎的第一次」 你发布的第一个帖子是什么？ 你关注的第一个好友是谁？ 你关注/交易的第一只股票是什么？ 【活动奖励】 凡是参与晒单的虎友均可获得66虎币，除此之外，还有机会获得以下奖励： 知己奖：我们会选取“第一条帖子”发帖时间最早的虎友赠予1套小虎盲盒手办（5个） 人气奖：我们会选取评论获赞量最高的3位虎友，随机赠予小虎盲盒手办1个 优质奖：我们会随机选取评论优质有趣的虎友，随机赠予小虎盲盒手办1个 【活动时间】： 2021年11月23日-11月29日 【特别说明】 水贴，重复内容，广告，恶意营销等属于无效内容； 文章需原创并首发于老虎，并且版权归老虎社区所有； 本次活动中用户所提到的标的，仅供参考，不构成投资建议，据此操作，风险自负； 活动最终解释权归老虎社区所有； 若对本次活动有不解之处，可在此贴留言，或微信虎妞（微信号：itiger2014）咨询。 欢迎大家在下贴评论区留言说说「你和老虎的第一次」，你发布的第一个帖子是什么？你关注的第一个好友是谁？你关注/交易的第一只股票是什么？参与即可获赠66虎币，如果你愿意多聊2句，还有机会获得小虎全套盲盒。","images":[{"img":"https://static.tigerbbs.com/b56d1364489aaafc34e363d2b2b842a8","width":"1462","height":"818"}],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/875266611","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":446,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":874434632,"gmtCreate":1637809697526,"gmtModify":1637809697589,"author":{"id":"3574933488250733","authorId":"3574933488250733","name":"DoubleClick","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574933488250733","authorIdStr":"3574933488250733"},"themes":[],"htmlText":"小米就是要放长线钓大鱼！<a href=\"https://laohu8.com/S/01810\">$XIAOMI-W(01810)$</a>","listText":"小米就是要放长线钓大鱼！<a href=\"https://laohu8.com/S/01810\">$XIAOMI-W(01810)$</a>","text":"小米就是要放长线钓大鱼！$XIAOMI-W(01810)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/874434632","repostId":"874394828","repostType":1,"repost":{"id":874394828,"gmtCreate":1637727980561,"gmtModify":1637730601856,"author":{"id":"3502767768442965","authorId":"3502767768442965","name":"话题虎","avatar":"https://static.tigerbbs.com/d418c2def5dc1d094b03270b450f71ce","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3502767768442965","authorIdStr":"3502767768442965"},"themes":[],"title":"小米净利润大长25.4%！为什么又跌了？何时能抄底？","htmlText":" 昨天，小米发布Q3财报： 营收781亿元，同比增长8.2%；净利润52亿元，同比增长25.4%。 分业务来看： 智能手机： 三季度收入478亿元。 手机销售单价同比增长6.7%，达到1,090.5元，整体毛利率同比增长4.4个百分点，达到12.8%； 本季度智能手机出货量4,390万部，排名世界第三，前三季出货量与去年全年相当； 高端旗舰手机出货量近1800万台，占比超12%。 IoT与生活消费产品： 三季度收入209亿元，同比增长15.5%； 平板、智能电视、空调出货量持续增加； 在可穿戴产品，第三季度全球市场份额排名第二。 互联网服务业务： 三季度收入73亿元，同比增长27.1%，创历史新高； 毛利率73.6%，同比提升13.1个百分点； 广告收入48亿元，同比增长44.7%； 游戏收入10亿元，同比增长25.0%。 从地区上看，三季度： 境外收入，占比高达52.4%； 小米手机在全球11个国家和地区市占率排名第一，在全球59个国家和地区市占率排名前五；在印度市场连续第16个季度保持出货量第一。 智能电动汽车和其他业务： 团队成员已超过500人，预计2024年上半年正式量产； AIoT平台已连接的IoT设备（不包括智能手机、平板及笔记本计算机）数首次突破4&nbsp;亿，同比增长33.1%； 小米在中国大陆的零售店总数已突破10,000家。 小话感觉小米又交出了一份非常ok的财报，可是为啥股价大跌呢？ 想不通。 …… 最后，大家聊一聊： 你认为小米的财报ok吗？小米跌到什么时候能抄底？ 精彩留言用户可获得888社区积分噢！ <a target=\"_blank\" href=\"https://laohu8.com/S/01810\">$小米集团-W(01810)$</a>","listText":" 昨天，小米发布Q3财报： 营收781亿元，同比增长8.2%；净利润52亿元，同比增长25.4%。 分业务来看： 智能手机： 三季度收入478亿元。 手机销售单价同比增长6.7%，达到1,090.5元，整体毛利率同比增长4.4个百分点，达到12.8%； 本季度智能手机出货量4,390万部，排名世界第三，前三季出货量与去年全年相当； 高端旗舰手机出货量近1800万台，占比超12%。 IoT与生活消费产品： 三季度收入209亿元，同比增长15.5%； 平板、智能电视、空调出货量持续增加； 在可穿戴产品，第三季度全球市场份额排名第二。 互联网服务业务： 三季度收入73亿元，同比增长27.1%，创历史新高； 毛利率73.6%，同比提升13.1个百分点； 广告收入48亿元，同比增长44.7%； 游戏收入10亿元，同比增长25.0%。 从地区上看，三季度： 境外收入，占比高达52.4%； 小米手机在全球11个国家和地区市占率排名第一，在全球59个国家和地区市占率排名前五；在印度市场连续第16个季度保持出货量第一。 智能电动汽车和其他业务： 团队成员已超过500人，预计2024年上半年正式量产； AIoT平台已连接的IoT设备（不包括智能手机、平板及笔记本计算机）数首次突破4&nbsp;亿，同比增长33.1%； 小米在中国大陆的零售店总数已突破10,000家。 小话感觉小米又交出了一份非常ok的财报，可是为啥股价大跌呢？ 想不通。 …… 最后，大家聊一聊： 你认为小米的财报ok吗？小米跌到什么时候能抄底？ 精彩留言用户可获得888社区积分噢！ <a target=\"_blank\" href=\"https://laohu8.com/S/01810\">$小米集团-W(01810)$</a>","text":"昨天，小米发布Q3财报： 营收781亿元，同比增长8.2%；净利润52亿元，同比增长25.4%。 分业务来看： 智能手机： 三季度收入478亿元。 手机销售单价同比增长6.7%，达到1,090.5元，整体毛利率同比增长4.4个百分点，达到12.8%； 本季度智能手机出货量4,390万部，排名世界第三，前三季出货量与去年全年相当； 高端旗舰手机出货量近1800万台，占比超12%。 IoT与生活消费产品： 三季度收入209亿元，同比增长15.5%； 平板、智能电视、空调出货量持续增加； 在可穿戴产品，第三季度全球市场份额排名第二。 互联网服务业务： 三季度收入73亿元，同比增长27.1%，创历史新高； 毛利率73.6%，同比提升13.1个百分点； 广告收入48亿元，同比增长44.7%； 游戏收入10亿元，同比增长25.0%。 从地区上看，三季度： 境外收入，占比高达52.4%； 小米手机在全球11个国家和地区市占率排名第一，在全球59个国家和地区市占率排名前五；在印度市场连续第16个季度保持出货量第一。 智能电动汽车和其他业务： 团队成员已超过500人，预计2024年上半年正式量产； AIoT平台已连接的IoT设备（不包括智能手机、平板及笔记本计算机）数首次突破4 亿，同比增长33.1%； 小米在中国大陆的零售店总数已突破10,000家。 小话感觉小米又交出了一份非常ok的财报，可是为啥股价大跌呢？ 想不通。 …… 最后，大家聊一聊： 你认为小米的财报ok吗？小米跌到什么时候能抄底？ 精彩留言用户可获得888社区积分噢！ $小米集团-W(01810)$","images":[{"img":"https://static.tigerbbs.com/3f5a17d57ed7aba34cdfe013be4ef460","width":"1024","height":"640"}],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/874394828","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"subType":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":549,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875615904,"gmtCreate":1637642120721,"gmtModify":1637642124644,"author":{"id":"3574933488250733","authorId":"3574933488250733","name":"DoubleClick","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574933488250733","authorIdStr":"3574933488250733"},"themes":[],"htmlText":"[Cool]&nbsp;","listText":"[Cool]&nbsp;","text":"[Cool]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/875615904","repostId":"1107351089","repostType":4,"isVote":1,"tweetType":1,"viewCount":764,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":874261442,"gmtCreate":1637793878586,"gmtModify":1637793878691,"author":{"id":"3574933488250733","authorId":"3574933488250733","name":"DoubleClick","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574933488250733","authorIdStr":"3574933488250733"},"themes":[],"htmlText":"我的计划是等着看","listText":"我的计划是等着看","text":"我的计划是等着看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/874261442","repostId":"874922613","repostType":1,"repost":{"id":874922613,"gmtCreate":1637722036227,"gmtModify":1637723087352,"author":{"id":"3527667596890271","authorId":"3527667596890271","name":"Buy_Sell","avatar":"https://static.tigerbbs.com/a5f0ed79a338c758a22e0b4ea13bf9d2","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3527667596890271","authorIdStr":"3527667596890271"},"themes":[],"title":"🚀【11月24日】涨跌不一，油价上演大逆转！今天什么值得买","htmlText":"聊聊今日份的交易想法，包括对于大盘走势后续的看法？看涨/看跌哪只股票、晒晒单等等。 港股市场 11月24日讯，港股三大指数开盘涨跌不一，恒指涨0.08%报24672点，国指跌0.02%报8825点，恒生科技指数跌0.1%报6317点。 盘面上，大型科技股多数延续跌势，<a target=\"_blank\" href=\"https://laohu8.com/S/09999\">$网易-S(09999)$</a> 跌2.44%，<a target=\"_blank\" href=\"https://laohu8.com/S/00700\">$腾讯控股(00700)$</a> 、<a target=\"_blank\" href=\"https://laohu8.com/S/09988\">$阿里巴巴-SW(09988)$</a> 、<a target=\"_blank\" href=\"https://laohu8.com/S/09618\">$京东集团-SW(09618)$</a> 均跌超1%，<a target=\"_blank\" href=\"https://laohu8.com/S/01024\">$快手-W(01024)$</a> 大涨4.5%；家电股、汽车股、半导体股、体育用品股、建材水泥股、燃气股普跌，内房股、保险股涨跌参半；国际油价上涨，石油股集体高开，<a target=\"_blank\" href=\"https://laohu8.com/S/00857\">$中国石油股份(00857)$</a> 涨超3%，恒大系继续走强，恒腾网络再涨3.58%。 <a target=\"_blank\" href=\"https://laohu8.com/S/01024\">$快手-W(01024)$</a> 绩后涨超4%，第三季度收入同比增33.4%，调整后净亏损48.22亿元。","listText":"聊聊今日份的交易想法，包括对于大盘走势后续的看法？看涨/看跌哪只股票、晒晒单等等。 港股市场 11月24日讯，港股三大指数开盘涨跌不一，恒指涨0.08%报24672点，国指跌0.02%报8825点，恒生科技指数跌0.1%报6317点。 盘面上，大型科技股多数延续跌势，<a target=\"_blank\" href=\"https://laohu8.com/S/09999\">$网易-S(09999)$</a> 跌2.44%，<a target=\"_blank\" href=\"https://laohu8.com/S/00700\">$腾讯控股(00700)$</a> 、<a target=\"_blank\" href=\"https://laohu8.com/S/09988\">$阿里巴巴-SW(09988)$</a> 、<a target=\"_blank\" href=\"https://laohu8.com/S/09618\">$京东集团-SW(09618)$</a> 均跌超1%，<a target=\"_blank\" href=\"https://laohu8.com/S/01024\">$快手-W(01024)$</a> 大涨4.5%；家电股、汽车股、半导体股、体育用品股、建材水泥股、燃气股普跌，内房股、保险股涨跌参半；国际油价上涨，石油股集体高开，<a target=\"_blank\" href=\"https://laohu8.com/S/00857\">$中国石油股份(00857)$</a> 涨超3%，恒大系继续走强，恒腾网络再涨3.58%。 <a target=\"_blank\" href=\"https://laohu8.com/S/01024\">$快手-W(01024)$</a> 绩后涨超4%，第三季度收入同比增33.4%，调整后净亏损48.22亿元。","text":"聊聊今日份的交易想法，包括对于大盘走势后续的看法？看涨/看跌哪只股票、晒晒单等等。 港股市场 11月24日讯，港股三大指数开盘涨跌不一，恒指涨0.08%报24672点，国指跌0.02%报8825点，恒生科技指数跌0.1%报6317点。 盘面上，大型科技股多数延续跌势，$网易-S(09999)$ 跌2.44%，$腾讯控股(00700)$ 、$阿里巴巴-SW(09988)$ 、$京东集团-SW(09618)$ 均跌超1%，$快手-W(01024)$ 大涨4.5%；家电股、汽车股、半导体股、体育用品股、建材水泥股、燃气股普跌，内房股、保险股涨跌参半；国际油价上涨，石油股集体高开，$中国石油股份(00857)$ 涨超3%，恒大系继续走强，恒腾网络再涨3.58%。 $快手-W(01024)$ 绩后涨超4%，第三季度收入同比增33.4%，调整后净亏损48.22亿元。","images":[{"img":"https://static.tigerbbs.com/8c224c9889536a14f83eca563ae0bb07","width":"666","height":"284"}],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/874922613","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"subType":2,"comments":[],"imageCount":2,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":886,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}